About Glycotest
Glycotest is a company based in New York (United States) founded in 2012.. Glycotest has raised $7 million across 3 funding rounds from investors including Fosun Pharmaceutical. Glycotest offers products and services including Glycotest Blood Tests. Glycotest operates in a competitive market with competitors including EchoSens, Fibronostics, Inner Mongolia Furui Medical Science, Bilhi Genetics and Wuxi Hisky Medical, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Glycotest, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7 M (USD)
in 3 rounds
-
Latest Funding Round
$1 M (USD), Series A
Jan 23, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Glycotest
Glycotest offers a comprehensive portfolio of products and services, including Glycotest Blood Tests. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Blood tests for early detection of liver cancers and fibrosis.
Unlock access to complete
Unlock access to complete
Funding Insights of Glycotest
Glycotest has successfully raised a total of $7M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $1 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $1.0M
-
First Round
First Round
(22 Oct 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series A - Glycotest | Valuation | Fosun Pharmaceutical |
|
| Nov, 2019 | Amount | Series A - Glycotest | Valuation | Fosun Pharmaceutical |
|
| Oct, 2018 | Amount | Series A - Glycotest | Valuation | Fosun Pharmaceutical |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Glycotest
Glycotest has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fosun Pharmaceutical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research, development, production, and sale of pharmaceuticals are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Glycotest
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Glycotest
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glycotest Comparisons
Competitors of Glycotest
Glycotest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EchoSens, Fibronostics, Inner Mongolia Furui Medical Science, Bilhi Genetics and Wuxi Hisky Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Non-invasive diagnostics for liver disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive algorithm-based diagnostics
|
|
| domain | founded_year | HQ Location |
Therapeutic and diagnostic solutions for liver diseases are provided.
|
|
| domain | founded_year | HQ Location |
Genetic markers are utilized for disease prediction algorithms.
|
|
| domain | founded_year | HQ Location |
Non-invasive liver diagnosis systems are manufactured using TE technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Glycotest
Frequently Asked Questions about Glycotest
When was Glycotest founded?
Glycotest was founded in 2012 and raised its 1st funding round 6 years after it was founded.
Where is Glycotest located?
Glycotest is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Glycotest?
Larry Cohen is the current CEO of Glycotest.
Is Glycotest a funded company?
Glycotest is a funded company, having raised a total of $7M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Oct 22, 2018.
What does Glycotest do?
Glycotest was founded in 2012 and is headquartered in New York, United States. Operations focus on the diagnostics sector, where non-invasive blood tests are developed to detect liver cancers and fibrosis-cirrhosis. The technology measures abnormal levels of the monosaccharide fucose on serum glycoproteins to identify disease causes. Leadership is provided by CEO Larry Cohen, with activities centered on advancing these diagnostic tools.
Who are the top competitors of Glycotest?
Glycotest's top competitors include EchoSens, Inner Mongolia Furui Medical Science and Fibronostics.
What products or services does Glycotest offer?
Glycotest offers Glycotest Blood Tests.
Who are Glycotest's investors?
Glycotest has 1 investor. Key investors include Fosun Pharmaceutical.